-
Name
adipiodone, dimeglumine salt
- EINECS
- CAS No. 3521-84-4
- Density g/cm3
- Solubility
- Melting Point
- Formula C20H14I6N2O6•2C7H17NO5
- Boiling Point 908.6°Cat760mmHg
- Molecular Weight 1530.26
- Flash Point 503.3°C
- Transport Information
- Appearance
- Safety Moderately toxic by several routes. When heated to decomposition it emits toxic fumes of I− and NOx.
- Risk Codes
-
Molecular Structure
- Hazard Symbols
- Synonyms X064O0Y1A4;UNII-X064O0Y1A4;
- PSA 366.14000
- LogP 2.21240
Biligrafin forte Chemical Properties
IUPAC Name: 3-[[6-(3-Carboxy-2,4,6-triiodoanilino)-6-oxohexanoyl]amino]-2,4,6-triiodobenzoic acid; (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
Synonyms of Biligrafin forte (CAS NO.3521-84-4): Sinografin ; 1-Deoxy-1-(methylamino)-D-glucitol 3,3'-(adipoyldiimino)bis(2,4,6-triiodobenzoate) (2:1) (salt) ; Adipiodone Meglumine Injection (JAN) ; Adipiodone meglumine ; Cavumbren ; Cholograf-N-methylglucamine ; Cholografin Meglumine ; EINECS 222-534-5 ; Endocistobil ; Endografin ; Endographin ; Intrabillix ; Intrablix ; Iodipamide meglumine ; Iodipamide meglumine salt ; Iodipamide methylglucamine salt ; Meglumine iodipamide ; Methyl glucamine biligrafin ; Methyl glucamine iodipamide ; Transbillix ; UNII-X064O0Y1A4 ; Ultrabil ; Adipiodone, dimeglumine salt ; Benzoic acid, 3,3'-((1,6-dioxo-1,6-hexanediyl)diimino)bis(2,4,6-triiodo-, compd. with 1-deoxy-1-(methylamino)-D-glucitol (1:2) ; Glucitol, 1-deoxy-1-(methylamino)-, 3,3'-(adipoyldiimino)bis(2,4,6-triiodobenzoate)(2:1) (salt), D- ; Iodipamide methylglucamine
CAS NO: 3521-84-4
Molecular Formula of Biligrafin forte (CAS NO.3521-84-4): C34H48I6N4O16
Molecular Weight: 1530.1889
H bond acceptors: 8
H bond donors: 4
Freely Rotating Bonds: 9
Polar Surface Area: 93.22 Å2
Flash Point of Biligrafin forte (CAS NO.3521-84-4): 503.3 °C
Enthalpy of Vaporization: 138.38 kJ/mol
Boiling Point: 908.6 °C at 760 mmHg
Vapour Pressure: 0 mmHg at 25°C
Molecular Structure:
.bmp)
Biligrafin forte Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| dog | LD50 | intravenous | 1200mg/kg (1200mg/kg) | Farmaco, Edizione Scientifica. Vol. 28, Pg. 996, 1973. | |
| mouse | LD50 | intravenous | 3195mg/kg (3195mg/kg) | Investigative Radiology. Vol. 15, Pg. S142, 1980. | |
| rabbit | LD50 | parenteral | 1446mg/kg (1446mg/kg) | Farmaco, Edizione Scientifica. Vol. 28, Pg. 1011, 1973. | |
| rat | LD50 | intravenous | 5gm/kg (5000mg/kg) | Drugs in Japan Vol. 6, Pg. 5, 1982. | |
| rat | LD50 | parenteral | 1921mg/kg (1921mg/kg) | Farmaco, Edizione Scientifica. Vol. 28, Pg. 1011, 1973. | |
| rat | LD50 | unreported | 5gm/kg (5000mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 26, Pg. 921, 1984. |
Biligrafin forte Safety Profile
Moderately toxic by several routes. When heated to decomposition it emits toxic fumes of I− and NOx.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View